APA (7th ed.) Citation

JS, L., Y, Z., S, S., L, X., HL, Z., JL, P., & Y, P. (2017). Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone. Dove Medical Press.

Chicago Style (17th ed.) Citation

JS, Liu, Zeng Y, Shi S, Xu L, Zhang HL, Pathak JL, and Pan Y. Design of Polyaspartic Acid Peptide-poly (ethylene Glycol)-poly (ε-caprolactone) Nanoparticles as a Carrier of Hydrophobic Drugs Targeting Cancer Metastasized to Bone. Dove Medical Press, 2017.

MLA (8th ed.) Citation

JS, Liu, et al. Design of Polyaspartic Acid Peptide-poly (ethylene Glycol)-poly (ε-caprolactone) Nanoparticles as a Carrier of Hydrophobic Drugs Targeting Cancer Metastasized to Bone. Dove Medical Press, 2017.